Skip to main content
OpenTrials

Clinical trial condition

Estrogen Receptor Negative

Explore clinical trials studying Estrogen Receptor Negative. Study availability and eligibility vary by location and protocol.

35 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Estrogen Receptor Negative trial results

Recruiting

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

NCT02945579

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
Locations
  • MD Anderson Cancer Center - Banner Gilbert, Arizona, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • Queen's Medical Center Honolulu, Hawaii, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, not recruiting

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

NCT02445391

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1024 locations
View Trial Details
Active, not recruiting

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

NCT02488967

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Southern Cancer Center PC-Springhill Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
View all 1296 locations
View Trial Details
Active, not recruiting

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

NCT02744053

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +8 more
Locations
  • Memorial Hermann Memorial City Medical Center Houston, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
View Trial Details
Completed

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

NCT01750073

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +20 more
Locations
  • Nebraska Medicine-Bellevue Bellevue, Nebraska, United States
  • CHI Health Saint Francis Grand Island, Nebraska, United States
  • Nebraska Medicine-Village Pointe Cancer Center Omaha, Nebraska, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details

Related conditions